Healthcare -
Biotechnology - NASDAQ - US
$ 4.55
-1.73 %
$ 156 M
Market Cap
-1.72
P/E
TARA - CAPITAL EXPENDITURES
Capital Expenditures TARA - Protara Therapeutics, Inc.
-45 K
LAST VALUE
72.52%
2 YEAR CAGR
17.67%
5 YEAR CAGR
-16.23%
10 YEAR CAGR